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The 4-10 fragment of adrenocort icotrophic hormone (ACTH4_10; Met-Glu-His-Phe-Arg-Trp-Gly) was adminis- 
tered intracerebroventricularly to C57B1 mice with and without  concurrent systemic injection of a standard dose 
of  morphine sulfate. Morphine produced s tereotyped behavioral activation (running, environmental oblivion, 
Straub tail) which was ai l tagonized in a dose related fashion by the ACTH fragment. This extends the range of 
opiate--ACTHa_l n interactions to  a novel species and behavioral model, and is consistent with previous findings. 
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1. Introduct ion 
Gispen, Terenius, and colleagues have dem- 
onstrated that fragments of ACTH which 
posess no intrinsic stimulating activity for the 
adrenal cortex are nonetheless active in a vari- 
ety ,of situations involving opiates. The 4-10 
peptide for example is known to antagonize 
opiate binding and analgesia in at least one 
species, the rat (summarized in Gispen et al., 
1977). Opiates and enkephalins produce pro- 
found behavioral excitation in mice, charac- 
terized by continual stereotyped horizontal 
motor activity, environmental oblivion, and 
Straub tail elevation (e.g. Katz et al., 1978). 
To further examine ACTH-opiate interactions 
in a novel species and behavioral model, we 
injected mice with' a: standard behaviorally 
effective dose of morphine and varying doses 
of ACTH4-10. The ACTH fragment reduced 
running in a dose related manner suggesting 
considerable behavioral generality for previ- 
ously established findings. 
2. Materials and methods  
2.1. Subjects 
60 adult male C57B1/2J mice 25--35 g each 
(Jackson Laboratories Inc., Bar Harbor, ME) 
were group housed 6/cage with food (Tedlad 
4.0% fat diet S-0836; Teklad, Inc., Madison, 
WI) and tap water continuously available. 
Day/night cycles of 12 h/12 h (lights on = 
8.00--20.00 h) were automatically pro- 
grammed. 
2.2. Surgery 
Each mouse was anesthetized with 50--80 
mg/kg sodium pentobarbital (Nembutal) and 
stereotaxically implanted with a 23 ga/stain- 
less steel cannula aimed at the lateral ven- 
tricle. The cannula was mounted on the skull 
with acrylic dental cement and stainless steel 
screws. Additional details of surgery and can- 
nula construction have been previously pre- 
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sented (Katz et al., 1978). A minimum of 4 
days recovery preceded further experimental 
procedures. 
2.3. Apparatus and behavioral procedure 
The field sensitive activity monitors used 
to measure locomotion (Stoelting, Chicago) 
have been described previously (Katz et al., 
1978). Subjects were individually placed in 
51 × 41 X 22 cm polypropylene cages {Scien- 
tific Products series 70) with a fresh pine chip 
bedding and allowed to habituate until 20 
min without  activity as registered upon the 
sensors. Each mouse was then briefly removed 
from the apparatus and centrally and sys- 
temically injected with drug or vehicle. Cen- 
tral injection was by a manually operated 
Hamilton microsyringe with infusion times of  
30 sec or less. Systemic injections were intra- 
peritoneal. Activity was then recorded for 21 
consecutive 10 min periods. 
2.4. Drugs 
Morphine sulfate was injected 50 mg/kg in 
a sterile 0.9% sodium chloride vehicle in a 10 
ml/kg injection volume. ACTH4_I0 {Peninsula 
No. 8750, San Carlos, CA) was injected 0, 7.5 
or 15 pg in a 5.0 /~1 of  Ringer--Locke solu- 
tion. The compound was prepared within 
48 h of use and stored at 4.0°C until injec- 
tion. 
3. Results 
All results are presented in fig. 1 as mean 
and standard error. The findings were ana- 
lyzed using two way analysis of  variance with 
repeated measures on time. By this technique 
the main drug effects were significant. F 
groups = 14.1 d.f. = 5,54 P < 0.01; F time = 
8.7 d.f. = 20,981 P <  0.01; F interaction = 
11.8 d.f. = 100,981 P < 0.01. Further compar- 
isons by Duncan's test indicated significant 
differences between morphine and control, 
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Fig. 1. Effec t  of  ACTH4_10 upon morphine- induced 
behavioral act ivat ion in the mouse.  Note  all open 
symbols  are morphine- injected,  all closed symbols  
vehicle-injected. Ordinate: mean ac t iv i ty /10  rain ± 
S.E.M.; abscissa: t ime (rain). Dose of  ACTH:  squares, 
0 pg;  circles: 7.5 pg;  triangles: 15.0 pg. Dose of  mor- 
phine:  solid symbols,  none ;  open symbols,  50 mg/kg. 
n = 10/group.  
morphine alone group. Therefore, the mor- 
phine treatment produced an increased activ- 
ity which was significantly reduced by  the 
peptide pretreatment.  
4. Discussion 
The present findings extend previous 
reports to a novel species and behavioral para- 
digm. The results confirm previous findings 
and suggest considerable generality to the 
behavioral interactions of opiates and 
ACTH4_10. The route of administration of  the 
latter and an absence of established adreno- 
cort icotrophic effects points to a central me- 
diation. Both ACTH and endorphins are con- 
tained within the structure of  ~-lipotropin 
which may be a naturally occurring parent 
compound for ACTH and endorphins (Guille- 
rain et al., 1977). Therefore, both previous 
and present studies may point to a normal 
biological control of activation and behavior 
by peptides concomitant ly released during 
stress. 
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